Extracorporeal shockwave therapy may be effective for intermittent lower limb claudication in peripheral artery disease (PAD) patients unable to engage in supervised exercise or who experienced little ...
Paclitaxel-coated balloons and paclitaxel-eluting stents should be withheld from routine use in patients with intermittent claudication until further evidence on their safety profile is available, an ...
Drug-coated stents and balloons were not associated with a reduction in amputations or improved quality of life compared with uncoated devices among patients with peripheral artery disease, according ...
The patient was told that his symptoms are consistent with intermittent claudication, a clinical diagnosis given for muscle pain (ache, cramp, numbness or sense of fatigue), classically in the calf, ...
HAIFA, Israel September 16, 2013 — Pluristem Therapeutics Inc. (NASDAQCM: PSTI) (TASE:PLTR), a leading developer of placenta-based cell therapies, announced today that the U.S. Food and Drug ...
MADRID -- Paclitaxel coating added no benefit to balloons and stents for endovascular peripheral arterial disease (PAD) intervention in the SWEDEPAD 1 and 2 trials -- and in fact, researchers said ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results